HDAC6 and neoplasm: As an inhibitor of histone deacetylase 6 (HDAC6), WT161 exerts anti-tumor effects by enhancing the acetylation of histones H3 and H4 on the promoter of the apoptosis-related gene BAD, prompting cell apoptosis and evoking anti-tumor responses [69].